| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/18/1999 | CA2298840A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/17/1999 | EP0896626A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| 02/17/1999 | CN1207946A Thioether conjugates |
| 02/16/1999 | US5872094 Method for attaching cartilaginous tissue, cartilage matrix protein or link protein to a surface |
| 02/16/1999 | US5872012 Protamine-reactive IGM antibodies |
| 02/16/1999 | US5871907 Methods for producing members of specific binding pairs |
| 02/16/1999 | US5871738 Nematode vaccine |
| 02/16/1999 | US5871732 Dna sequences and genetic engineering for aids |
| 02/16/1999 | CA2122112C Adrenomedullin |
| 02/16/1999 | CA2000913C Family of high affinity antibodies for cancer treatment |
| 02/11/1999 | WO1999006577A2 Agent for expressing and detecting a fusion polypeptide with an hpol-epitope and a polypeptide |
| 02/11/1999 | WO1999006557A2 Mammalian cell membrane proteins; related reagents |
| 02/11/1999 | WO1999006551A2 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
| 02/11/1999 | WO1999006549A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES |
| 02/11/1999 | WO1999006540A2 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | WO1999006539A1 Zggbp1, novel peptides related to bipolar affective disorder type 1, sequences and uses thereof |
| 02/11/1999 | WO1999006439A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM |
| 02/11/1999 | DE19733389A1 Mittel zur Expression und zum Nachweis eines ein HPOL-Epitop und ein Polypeptid umfassenden Fusionspolypeptids Means for expression and detection of a HPOL epitope and a polypeptide comprising the fusion polypeptide |
| 02/11/1999 | CA2298115A1 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | CA2297157A1 5' ests for secreted proteins expressed in testis and other tissues |
| 02/11/1999 | CA2296809A1 5' ests for secreted proteins identified from brain tissues |
| 02/11/1999 | CA2296398A1 5' ests for secreted proteins expressed in endoderm |
| 02/10/1999 | EP0597843B1 16 kDa SURFACE PROTEIN OF P. FALCIPARUM |
| 02/10/1999 | CN1207686A FC 'epsilon'-PE chimeric protein for targeted treatment of allergy responses, method for its production and pharmaceutical compositions contg. same |
| 02/09/1999 | US5869618 For diagnosis of cancers related to erbb-2 oncogene expression |
| 02/09/1999 | US5869610 Isolated polypeptide identified as a cytokine receptor containing extracellular, transmembrane and intracellular domains; prenatal testing and cancer diagnosis |
| 02/09/1999 | US5869292 Producing genetically engineered protein by replacing at least one acidic region of factor viii with acidic region of hirudin or heparin cofactor ii; increased coagulant activity |
| 02/09/1999 | US5869282 Nucleotide and protein sequences of the serrate gene and methods based thereon |
| 02/09/1999 | US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/09/1999 | US5869270 Single chain MHC complexes and uses thereof |
| 02/09/1999 | US5869232 Amino acid sequence of antibody binding to specific antigen (or hapten) covalently linked to second amino acid sequence to which a second antibody binds; redirecting specificity of antibody |
| 02/09/1999 | US5869049 Methods of inducing T cell unresponsiveness to bone marrow with gp39 antagonists |
| 02/09/1999 | CA1340381C Recombinant fusion proteins |
| 02/04/1999 | WO1999004820A2 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
| 02/04/1999 | CA2296798A1 Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents |
| 02/03/1999 | CN1207132A Psudomonas exotoxin-myelin basic protein chimeric proteins |
| 02/03/1999 | CN1207131A Recombinant fusion proteins to growth hormone and serum albumin |
| 02/02/1999 | US5866779 Recombinant gibberellin DNA and uses thereof |
| 02/02/1999 | US5866755 Animals transgenic for a tetracycline-regulated transcriptional inhibitor |
| 02/02/1999 | US5866694 Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates |
| 02/02/1999 | US5866692 Process for producing humanized chimera antibody |
| 02/02/1999 | US5866402 Chimeric MCP and DAF proteins with cell surface localizing domain |
| 02/02/1999 | US5866372 Investigation and diagnosis of anaplastic large-cell lymphomas. |
| 02/02/1999 | US5866371 Process for using the yeast ADH II promoter system for the production of heterologous proteins in high yields |
| 02/02/1999 | US5866364 Recombinant bone morphogenetic protein heterodimers |
| 02/02/1999 | US5866129 Method of producing an antibody with a peptide corresponding to membrane-bound IgA |
| 02/02/1999 | US5866124 Antiidiotypic antibodies for high molecular weight-melanoma associated antigen |
| 02/02/1999 | CA2100671C Serine rich peptide linkers |
| 01/28/1999 | WO1999004000A1 Adipocyte-specific protein homologs |
| 01/28/1999 | WO1999003997A1 Humanized and green fluorescent protein genes and methods |
| 01/28/1999 | WO1999003987A2 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 01/28/1999 | WO1999003881A2 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest |
| 01/28/1999 | WO1999003508A2 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 01/28/1999 | WO1998046636A3 β-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
| 01/28/1999 | CA2296736A1 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 01/28/1999 | CA2296530A1 Adipocyte-specific protein homologs |
| 01/27/1999 | EP0892854A2 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 01/27/1999 | EP0892811A2 Peptides with antiproliferative properties |
| 01/27/1999 | EP0892809A1 Fhit proteins and nucleic acids and methods based thereon |
| 01/27/1999 | EP0461177B1 Human intra-acrosomal sperm antigen for use in a contraceptive vaccine |
| 01/27/1999 | CN1206350A Hybrid with interferon-'alpha' and immunoglobulin Fc linkes through non-immunogenic peptide |
| 01/26/1999 | US5864020 A monoclonal antibody specifically binds to a hepatoma transmembrane kinase receptor ligand having selective amino acid sequence |
| 01/26/1999 | US5864019 Antigen-binding protein comprising: 3 or 4 vh domains; spacing polypeptide attached to c-terminal end of each vh domain; linkage polypeptide containing linkable residues attached to c-terminal end of each spacing polypeptide; vl domain |
| 01/26/1999 | US5864013 Materials for the production of nanometer structures and use thereof |
| 01/26/1999 | US5864010 Enzyme inhibitor; antiinflammatory agent |
| 01/26/1999 | US5863899 Analgesics and antiinflammatory agent; a morphine or derivative is attached to brandykinin antagonist peptide by maleimido or amino acid analog linker |
| 01/26/1999 | US5863891 Protein fragments joined by peptide bonds |
| 01/26/1999 | US5863765 Connecting nucleotide sequences, transformation, cultures and cleavage of peptide sites |
| 01/26/1999 | CA2137639C Vaccine composition comprising autologous epidermal growth factor or a fragment or a derivate thereof having anti-tumor activity and use thereof in the therapy of malignant diseases |
| 01/26/1999 | CA1340350C Monoclonal antibody to the 75 kd subunit of the human interleukin-2 receptor and use thereof |
| 01/26/1999 | CA1340328C Method for protein binding enzyme complementation assays |
| 01/21/1999 | WO1999002991A1 Antibodies and scfv immunotoxins specific to imported fire ants, and their application |
| 01/21/1999 | WO1999002711A2 Fusion proteins with an immunoglobulin hinge region linker |
| 01/21/1999 | WO1999002710A1 Production and use of recombinant protein multimers with altered biological activity |
| 01/21/1999 | WO1999002708A1 Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein |
| 01/21/1999 | WO1999002707A1 Fusion proteins comprising coiled-coil structures |
| 01/21/1999 | WO1999002681A1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof |
| 01/21/1999 | WO1999002562A1 Isolated dendritic cell membrane protein genes |
| 01/21/1999 | WO1999002178A1 Therapeutic agent for the treatment of septicaemia, its preparation and use |
| 01/21/1999 | CA2715850A1 Isolated dendritic cell membrane protein genes |
| 01/21/1999 | CA2296071A1 Production and use of recombinant protein multimers with altered biological activity |
| 01/21/1999 | CA2295914A1 Antibodies and scfv immunotoxins specific to imported fire ants, and their application |
| 01/21/1999 | CA2295149A1 Fusion proteins with an immunoglobulin hinge region linker |
| 01/21/1999 | CA2292791A1 Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein |
| 01/21/1999 | CA2290716A1 Fusion proteins comprising coiled-coil structures |
| 01/20/1999 | EP0892052A1 Sodium-bicarbonate transporter polypeptides |
| 01/20/1999 | EP0891982A2 HIV peptides |
| 01/20/1999 | EP0891425A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 01/20/1999 | EP0597960B1 Treatment of cell populations |
| 01/20/1999 | CN1205738A OB protein derivatives having prolonged half-life |
| 01/19/1999 | US5861497 Trabecular meshwork induced glucocorticoid response (TIGR) nucleic acid molecules |
| 01/19/1999 | US5861379 Chimeric fatty body-pro-GRF analogs with increased biological potency |
| 01/19/1999 | US5861275 Lantibiotic mutants and chimeras of enhanced stability and activity, leader sequences therefor, genes encoding the same, and methods of producing and using the same |
| 01/19/1999 | US5861161 Chimeric proteins comprising a Vpr/Vpx virion incorporation domain for targeting into HIV-1 or HIV-2 virions |
| 01/19/1999 | US5861151 Soluble fusion molecules with binding specificity for cell adhesion molecules |
| 01/19/1999 | CA2105382C Recombinant hybrid porin epitopes |
| 01/19/1999 | CA1340327C Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 01/16/1999 | CA2237784A1 Novel compounds |
| 01/14/1999 | WO1999001549A1 Transcriptional activators with graded transactivation potential |
| 01/14/1999 | DE19729810A1 Mittel zur Sepsistherapie, seine Herstellung und seine Verwendung Means for sepsis therapy, its preparation and its use |